Safety and efficacy of intravitreal injection of conbercept for the treatment of patients with choroidal neovascularization secondary to pathological myopia: Results from the SHINY study
机构:[1]Department of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing, China.临床科室眼科眼科首都医科大学附属北京同仁医院首都医科大学附属同仁医院[2]Department of Ophthalmology, Chinese PLA General Hospital of Central Theater Command, Wuhan, China.[3]Department of Ophthalmology, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai General Hospital, Shanghai, China.[4]Department of Ophthalmology, West China Hospital of Sichuan University, Chengdu, China.四川大学华西医院[5]Department of Ophthalmology, Peking University Third Hospital, Beijing, China.[6]Department of Ophthalmology, Peking Union Medical College Hospital, Beijing, China.[7]Department of Ophthalmology, Wuxi No.2 People's Hospital, Nanjing Medical University, Wuxi, China.[8]Department of Ophthalmology, Daping Hospital and Institute of Surgery Research, Army Medical University, Chongqing, China.[9]National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China.[10]State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China.[11]Department of Ophthalmology, He Eye Specialist Hospital, Chongqing, China.[12]Department of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi'an, China.[13]Department of Ophthalmology, Qingdao Eye Hospital of Shandong First Medical University, Qingdao, China.[14]Medical Research Center, Chengdu Kanghong Biotechnology Inc, Chengdu, China.
第一作者机构:[1]Department of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing, China.
通讯作者:
推荐引用方式(GB/T 7714):
Gao Liqin,Song Yanping,Sun Xiaodong,et al.Safety and efficacy of intravitreal injection of conbercept for the treatment of patients with choroidal neovascularization secondary to pathological myopia: Results from the SHINY study[J].ACTA OPHTHALMOLOGICA.2024,102(4):e577-e586.doi:10.1111/aos.15810.
APA:
Gao Liqin,Song Yanping,Sun Xiaodong,Zhang Junjun,Liu Yuling...&Zhang Feng.(2024).Safety and efficacy of intravitreal injection of conbercept for the treatment of patients with choroidal neovascularization secondary to pathological myopia: Results from the SHINY study.ACTA OPHTHALMOLOGICA,102,(4)
MLA:
Gao Liqin,et al."Safety and efficacy of intravitreal injection of conbercept for the treatment of patients with choroidal neovascularization secondary to pathological myopia: Results from the SHINY study".ACTA OPHTHALMOLOGICA 102..4(2024):e577-e586